mRNA Manufacturing | Essentials
Summary
This comprehensive short course explores end-to-end mRNA manufacturing, with a particular focus on vaccine and therapeutic development. It integrates foundational theory with extensive hands-on training in a state-of-the-art laboratory environment, allowing participants to translate conceptual knowledge into practical skills and gain direct experience with contemporary mRNA manufacturing technologies. Participants will perform each major unit operation across the mRNA manufacturing workflow, including mRNA synthesis by in vitro transcription, downstream purification and quality assessment, and lipid nanoparticle formulation and characterisation. Through these guided laboratory activities, participants will generate, analyse, and interpret experimental data, and apply these insights in integrated problem-solving sessions to identify, troubleshoot, and resolve common process challenges encountered in mRNA manufacturing.
| Format | Blended learning. Online self-paced pre-learning and in-person training |
|---|---|
| Location | Monash University, Clayton campus, Victoria, Australia |
| Duration | Online: 6 hours In-person: 5 days |
| Fees | AUD 4,995 incl. GST |
| Target Audience | The mRNA Manufacturing | Essentials training short course is positioned at an intermediate level. Participants are expected to have foundational knowledge of mRNA or prior training in related disciplines, including (but not limited to) molecular biology, chemistry, biology, pharmacology, or pharmaceutical science. This short course is best suited to individuals interested in pursuing research or industry roles that involve the manufacture of mRNA. |
Highlights
This short course consists of online pre-learning modules and face-to-face sessions. Participants will complete six online pre-learning modules at their own pace to support the performance of the laboratory activities. Our expert facilitators will lead the hands-on laboratory components that will empower participants to synthesise, purify and analyse mRNA constructs.
This program has been developed in collaboration with CPI's RNA Training Academy (UK) - a leading centre in RNA innovation and workforce development.
- Training informed by real-world RNA manufacturing and scale-up environments
- Developed by experts in RNA therapeutics and lipic nanoparticle (LNP) technologies
- Aligned to the skills needed across the global mRNA workforce
This ensures the learning is practical, current, and industry informed.
Enrolment into this short course is subject to Terms and Conditions.
